Functional interaction between amino-acid residues 242 and 290 in cytochromes P-450 2B1 and 2B11

https://doi.org/10.1016/S0167-4838(96)00209-9Get rights and content

Abstract

Previous studies have revealed the functional importance of the negatively charged amino-acid residue Asp-290 of the phenobarbital-inducible dog liver cytochrome P-450 (P-450) 2B11 (Harlow, G.R. and Halpert J.R. (1996) Arch. Biochem. Biophys. 326, 85–92). A search for P-450 2B11 residues capable of forming a charge pair with Asp-290 suggested the positively charged residue Lys-242 as a likely candidate. Replacement of Lys-242 with Asp in a P-450 2B11 fusion protein with rat NADPH-cytochrome P-450 reductase (reductase) resulted in very low holoenzyme expression levels in Escherichia coli, as did replacement of Asp-290 with Lys. Remarkably, however, expression levels of the double mutant Lys-242→Asp/Asp-290→Lys were dramatically increased above either single replacement alone. Similarly, the pair-wise substitutions Lys-242→Leu/Asp-290→Ile in P-450 2B11 and Leu-242→Lys/Ile-290→Asp in P-450 2B1 showed greater holoenzyme expression levels than the constituent single mutants, providing further evidence for the close proximity of these residues within the three-dimensional structure of these two enzymes. These results support the hypothesis that a functional interaction exists between residues 242 and 290, which may help to coordinate the relative positions of proposed helices G and I. All of the mutant combinations, including the additional P-450 2B11 double mutants Tyr-242/Asn-290 and Tyr-242/Ser-290, displayed altered stereoselectivity of androstenedione hydroxylation.

Introduction

The cytochrome P-450 superfamily comprises a large group of hemoproteins that are capable of metabolizing a wide variety of both endogenous and exogenous compounds. Recent work in this laboratory has primarily focused on the structural basis of substrate specificity of various enzymes of the P-450 2B subfamily, including rat 2B1 1, 2, 3, 4, 5, 6, 7, 8, rabbit 2B4 and 2B5 9, 10, 11, and the phenobarbital-inducible dog liver P-450 2B11 10, 12. In previous studies, the replacement of Asp-290 in P-450 2B11 with Ile, which is the equivalent residue in rat P-450 2B1, altered the metabolism of androstenedione (AD), testosterone, 7-ethoxycoumarin, (R)- and (S)-warfarin, and 2,2′,4,4′,5,5′-hexachlorobiphenyl [12]. The lack of charge on these substrates suggested that Asp-290 may have a structural rather than direct catalytic role. It was subsequently shown that both the charge and size of residue 290 in P-450 2B11 have functional significance [13]. In that study, all eleven substitutions tested for Asp-290 in P-450 2B11 resulted in decreased enzyme activities. The replacement D290E yielded the highest activity (55% of wild-type), while substituting the positively charged amino-acid Arg for Asp-290 created an enzyme with the lowest activity (<1% of wild-type activity).

In the absence of an X-ray crystal structure for any mammalian P-450, computer-aided modeling of P-450 2B1 7, 8based on analogy with bacterial enzymes of known crystal structure, suggests that residue 290 of P-450 2B1 may be relatively buried inside the enzyme. The energetic cost of inserting a charged residue into a low dielectric environment is high, but inserting a salt bridge into a hydrophobic environment can be energetically much more favorable [14]. Mutagenesis studies of salt bridges buried within hydrophobic regions of other proteins have demonstrated that these types of interactions play a crucial role in determining protein conformation or folding dynamics 15, 16, 17, 18, 19. However, the exact role of buried salt bridges is not certain and is a subject of current interest [20].

Residue-residue interactions can be very valuable in confirming enzyme structure predictions. Recent results with P-450 2C enzymes have demonstrated that certain residues in positions predicted by alignment with bacterial P-450s interact with each other [21], thus validating a portion of the proposed P-450 2C three-dimensional structure. In the present study, heterologous expression of site-specifically mutated forms of dog P-450 2B11 and rat P-450 2B1 were used to study whether residue 242 forms a functional interaction with residue 290. Our analysis identifies a potential salt bridge between Asp-290 and Lys-242 in P-450 2B11, which apparently helps determine protein folding, protein stability, and/or enzyme active-site characteristics.

Section snippets

Materials

Restriction endonucleases were purchased from Gibco-BRL (Grand Island, NY) and Stratagene Cloning Systems (La Jolla, CA). Taq DNA polymerase was obtained from Boehringer-Mannheim (Indianapolis, IN). Growth media for Escherichia coli (E. coli) were from Difco (Detroit, MI). Androstenedione, NADPH, δ-aminolevulinic acid, and IPTG were purchased from Sigma (St. Louis, MO). [4-14C]Androstenedione was from DuPont-New England Nuclear (Boston, MA). TLC plates were obtained from J.T. Baker

Substitution of Lys-242 with Asp in P-450 2B11

It was previously noted [12]that the turnover number of the P-450 2B11 mutant D290I was greatly reduced for five substrates, except for production of a minor metabolite of testosterone. The absence of a positive charge on any of the substrates tested suggested that the negative charge on Asp-290 was not interacting directly with the substrate. Since the presence of a charge at residue 290 is unique to P-450 2B11 among the 2B subfamily of enzymes, a search was made for a unique positively

Discussion

The computer-predicted structure of P-450 2B1 [7]and a search for positively charged amino-acid residues unique to P-450 2B11 which might be interacting with the unique negatively charged Asp-290 led us to the prediction that Lys-242 is interacting with Asp-290. The most direct approach to test this would have been to examine the crystal structures of wild-type and mutant enzymes and determine the structural consequences of site-directed changes at these positions, as was done for analysis of a

Acknowledgements

We thank Dr. Grazyna Szklarz of the University of Arizona for assistance in locating probable positions of certain P-450 2B1 residues. This work was supported by grants from the National Institutes of Health ES04995 (J.R.H.), Center Grant ES06694 (University of Arizona), and Institutional Training Grant ES07091 (G.R.H.).

References (32)

  • Kedzie, K.M., Balfour, C.A., Escobar, G.Y., Grimm, S.W., He, Y.-A., Pepperl, D.J., Regan, J.W., Stevens, J.C. and...
  • He, Y.A., Balfour, C.A., Kedzie, K.M. and Halpert, J.R. (1992) Biochemistry 31,...
  • Halpert, J.R. and He, Y.A. (1993) J. Biol. Chem. 268,...
  • He, Y., Luo, Z., Klekotka, P.A., Burnett, V.L. and Halpert, J.R. (1994) Biochemistry 33,...
  • Luo, Z., He, Y. and Halpert, J.R. (1994) Arch. Biochem. Biophys. 309,...
  • He, Y.Q., He, Y.A. and Halpert, J.R. (1995) Chem. Res. Toxicol. 8,...
  • Szklarz, G.D., He, Y.A. and Halpert, J.R. (1995) Biochemistry 34,...
  • Szklarz, G.D., Ornstein, R.L. and Halpert, J.R. (1994) J. Biomol. Struct. Dyn. 12,...
  • Szklarz, G.D., He, Y.Q., Kedzie, K.M., Halpert, J.R. and Burnett, V.L. (1996) Arch. Biochem. Biophys. 327,...
  • Liu, J., He, Y.A. and Halpert, J.R. (1996) Arch. Biochem. Biophys. 327,...
  • Kedzie, K.M., Grimm, S.W., Chen, F. and Halpert, J.R. (1993) Biochim. Biophys. Acta 1164,...
  • Hasler, J.A., Harlow, G.R., Szklarz, G.D., John, G.H., Kedzie, K.M., Burnett, V.L., He, Y.-A., Kaminsky, L.S. and...
  • Harlow, G.R. and Halpert, J.R. (1996) Arch. Biochem. Biophys. 326,...
  • Honig, B.H. and Hubbell, W.L. (1984) Proc. Natl. Acad. Sci. USA 81,...
  • Dunten, R.L., Sahin-Toth, M. and Kaback, H.R. (1993) Biochemistry 32,...
  • Frillingos, S., Sahin-Toth, M., Lengeler, J.W. and Kaback, H.R. (1995) Biochemistry 34,...
  • Cited by (30)

    • The role of cytochrome P450 2B6 and 2B4 substrate access channel residues predicted based on crystal structures of the amlodipine complexes

      2014, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      The molecular chaperone plasmid pGro7, which expresses GroES/EL, was obtained from TAKARA BIO (Shiba, Japan). Recombinant NADPH cytochrome P450 reductase (CPR) and cytochrome b5 from rat liver were prepared as described previously [32]. All other chemicals and supplies used were from standard sources.

    • X-ray crystal structure of the cytochrome P450 2B4 active site mutant F297A in complex with clopidogrel: Insights into compensatory rearrangements of the binding pocket

      2013, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      TOPP3 cells were from Stratagene (La Jolla, CA). Recombinant NADPH cytochrome P450 reductase (CPR) and cytochrome b5 from rat liver were prepared as described previously [27]. All other chemicals and supplies used were from standard sources.

    • Identification and analysis of conserved sequence motifs in cytochrome P450 family 2: Functional and structural role of a motif<sup>187</sup> RFDYKD <sup>192</sup> in CYP2B enzymes

      2008, Journal of Biological Chemistry
      Citation Excerpt :

      4-CPI, BIF, NADPH, and H2O2 were bought from Sigma. Recombinant NADPH-cytochrome P450 reductase (CPR) and cytochrome b5 (b5) from rat liver were prepared as described previously (27). Oligonucleotide primers for PCR were obtained from Sigma Genosys (Woodlands, TX).

    • Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide

      2007, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      IFA was obtained from the Drug Synthesis and Chemistry Branch of the National Cancer Institute (Bethesda, MD). Recombinant NADPH-cytochrome P450 reductase (CPR) and cytochrome b5 from rat liver were prepared as described previously [27]. Oligonucleotide primers for polymerase chain reaction (PCR) were obtained from Sigma Genosys (Woodlands, TX).

    • Directed evolution of mammalian cytochrome P450 2B1: Mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide

      2005, Journal of Biological Chemistry
      Citation Excerpt :

      IFA was obtained from the Drug Synthesis and Chemistry Branch of the NCI, National Institutes of Health. Recombinant NADPH-cytochrome P450 reductase (CPR) and cytochrome b5 (b5) from rat liver were prepared as described previously (27). Oligonucleotide primers for PCR were either obtained from The University of Texas Medical Branch, (UTMB), Molecular Biology Core Laboratory (Galveston, TX) or from Sigma Genosys (Woodlands, TX).

    View all citing articles on Scopus
    View full text